| Genome-wide association study identifies five new schizophrenia loci Nature genetics 43 (10), 969-976, 2011 | 1993 | 2011 |
| Common variants conferring risk of schizophrenia H Stefansson, RA Ophoff, S Steinberg, OA Andreassen, S Cichon, ... Nature 460 (7256), 744-747, 2009 | 1939 | 2009 |
| Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats M Tang-Christensen, PJ Larsen, R Goke, A Fink-Jensen, DS Jessop, ... American Journal of Physiology-Regulatory, Integrative and Comparative …, 1996 | 779 | 1996 |
| Reducing the treatment gap for mental disorders: a WPA survey V Patel, M Maj, AJ Flisher, MJ De Silva, M Koschorke, M Prince, ... World Psychiatry 9 (3), 169-176, 2010 | 392 | 2010 |
| The γ-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats A Fink-Jensen, PD Suzdak, MDB Swedberg, ME Judge, L Hansen, ... European journal of pharmacology 220 (2-3), 197-201, 1992 | 209 | 1992 |
| Xanomeline, an M1/M4 preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice HE Shannon, K Rasmussen, FP Bymaster, JC Hart, SC Peters, ... Schizophrenia research 42 (3), 249-259, 2000 | 200 | 2000 |
| Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine-or olanzapine-treated patients with schizophrenia spectrum disorder: a randomized clinical … JR Larsen, L Vedtofte, MSL Jakobsen, HR Jespersen, MI Jakobsen, ... JAMA psychiatry 74 (7), 719-728, 2017 | 178 | 2017 |
| A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors J Jeon, D Dencker, G Wörtwein, DPD Woldbye, Y Cui, AA Davis, AI Levey, ... Journal of Neuroscience 30 (6), 2396-2405, 2010 | 168 | 2010 |
| Role for M5 muscarinic acetylcholine receptors in cocaine addiction A Fink‐Jensen, I Fedorova, G Wörtwein, DPD Woldbye, T Rasmussen, ... Journal of neuroscience research 74 (1), 91-96, 2003 | 161 | 2003 |
| Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management S Fanoe, D Kristensen, A Fink-Jensen, HK Jensen, E Toft, J Nielsen, ... European heart journal 35 (20), 1306-1315, 2014 | 153 | 2014 |
| Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study L Baandrup, C Gasse, VD Jensen, BY Glenthoj, M Nordentoft, H Lublin, ... The Journal of clinical psychiatry 70 (2), 1111, 2009 | 143 | 2009 |
| Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice M Thomsen, DPD Woldbye, G Wörtwein, A Fink-Jensen, J Wess, ... Journal of Neuroscience 25 (36), 8141-8149, 2005 | 142 | 2005 |
| Clinical characteristics and predictors of outcome of schizophrenia-spectrum psychosis in children and adolescents: a systematic review M Stentebjerg-Olesen, AK Pagsberg, A Fink-Jensen, CU Correll, ... Journal of Child and Adolescent Psychopharmacology 26 (5), 410-427, 2016 | 132 | 2016 |
| Acute antipsychotic treatment of children and adolescents with schizophrenia-spectrum disorders: a systematic review and network meta-analysis AK Pagsberg, S Tarp, D Glintborg, AD Stenstrøm, A Fink-Jensen, ... Journal of the American Academy of Child & Adolescent Psychiatry 56 (3), 191-202, 2017 | 116 | 2017 |
| Regional brain volumes, diffusivity, and metabolite changes after electroconvulsive therapy for severe depression A Jorgensen, P Magnusson, LG Hanson, T Kirkegaard, H Benveniste, ... Acta Psychiatrica Scandinavica 133 (2), 154-164, 2016 | 114 | 2016 |
| The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice G Sørensen, IA Reddy, P Weikop, DL Graham, GD Stanwood, G Wortwein, ... Physiology & behavior 149, 262-268, 2015 | 107 | 2015 |
| Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain A Fink-Jensen, P Kristensen Neuroscience letters 182 (1), 115-118, 1994 | 104 | 1994 |
| Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R, 6R) 6-(3-propylthio-1, 2, 5-thiadiazol-4-yl)-1-azabicyclo [3.2. 1] octane FP Bymaster, HE Shannon, K Rasmussen, NW Delapp, CH Mitch, ... European journal of pharmacology 356 (2-3), 109-119, 1998 | 103 | 1998 |
| Glucagon‐like peptide‐1 receptor agonists for antipsychotic‐associated cardio‐metabolic risk factors: A systematic review and individual participant data meta‐analysis D Siskind, M Hahn, CU Correll, A Fink‐Jensen, AW Russell, N Bak, ... Diabetes, Obesity and Metabolism 21 (2), 293-302, 2019 | 100 | 2019 |
| The muscarinic M1/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys MB Andersen, A Fink-Jensen, L Peacock, J Gerlach, F Bymaster, ... Neuropsychopharmacology 28 (6), 1168-1175, 2003 | 99 | 2003 |
